Positive
EQUAL
Narjust Florez/LinkedIn

Narjust Florez: EQUAL Study on Early EGFR Lung Cancer Diagnosis will be Presented at ASCO25

Narjust Florez, Co-Director of the Young Lung Cancer Program at Dana-Farber Cancer Institute, shared a post on LinkedIn:

“Our study in progress, EQUAL, which aims to evaluate a novel blood assay for early diagnosis of EGFR lung cancer, will be presented at ASCO25 during the Monday poster session. See you there!”

More posts featuring Narjust Florez.

ASCO25 cancer EGFR lung cancer EQUAL Lung cancer Narjust Florez OncoDaily Oncology